ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 679516 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 679516; 2) Community: the network communities that were significantly associated with the response to NSC 679516; 3) Molecule: the relationships between components within communities and NSC 679516; 4) MDR: the compounds that were significantly associated with the NSC 679516.

NSC Compound Enrichment Correlation
NSC 648365 Insulin-Methotrexate conjugate 0.0186186224062458 0.23210497
NSC 658455 (S,S)(-)3,5-Dimethoxy N-(.alpha.-Phenethyl)phenyl isopropylamine 0.0186186224062458 0.46455179
NSC 665484 Null 0.0186186224062458 0.31574233
NSC 671865 Null 0.0186186224062458 0.24934301
NSC 676343 Null 0.0186186224062458 0.059184777
NSC 678401 Glycine, N-[N-[[(4-methoxyphenyl)azo]carbonyl]-L-leucyl]-, dicyclohexylamine salt 0.0186186224062458 0.33543822
NSC 68091 WLN: WS3&1U1SW3 -T 0.0186186224062459 0.22451705
NSC 680931 Null 0.0186186224062459 0.43910134
NSC 682827 Propanimidoyl chloride, 2-methyl- N-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]oxy]- 0.0186186224062459 0.19425724
NSC 682831 Butanimidoyl chloride, N-[[[(3-fluorophenyl)amino] carbonyl]oxy]- 0.0186186224062459 0.23301832
Total:120  Current:59    [First] [Prev] [Next] [Last]